Last reviewed · How we verify
Pseudoephedrine Pill — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Pseudoephedrine Pill (Pseudoephedrine Pill) — John Muir Health.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pseudoephedrine Pill TARGET | Pseudoephedrine Pill | John Muir Health | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pseudoephedrine Pill CI watch — RSS
- Pseudoephedrine Pill CI watch — Atom
- Pseudoephedrine Pill CI watch — JSON
- Pseudoephedrine Pill alone — RSS
Cite this brief
Drug Landscape (2026). Pseudoephedrine Pill — Competitive Intelligence Brief. https://druglandscape.com/ci/pseudoephedrine-pill. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing